While pharmaceutical companies are most familiar with roles of the Food and Drug Administration (FDA)'s Office of Prescription Drug Promotion (OPDP) and Federal Trade Commission, prescription drug-focused companies may now also want to anticipate increased scrutiny of advertising by competitors.